FDA Launches AEMS Adverse Event Safety Platform
SILVER SPRING, Md., March 11, 2026 The U.S. Food and Drug Administration (FDA) has launched a new unified safety...
.Gov for New Therapy
FDA Unveils New Biosimilar Guidance to Cut Development Costs
Washington, D.C., United States – March 10, 2026 The U.S. Food and Drug Administration (FDA) has released updated draft...
UK Launches Landmark Online Child Safety Review
LONDON, March 2, 2026 The UK Government has launched a landmark national consultation on children’s digital wellbeing, opening a...
FDA Grants Priority Approval to Hernexeos for NSCLC
WASHINGTON, D.C., February 26, 2026 The U.S. Food and Drug Administration (FDA) has granted approval to Hernexeos (zongertinib) for...
SEC Proposes Fund Portfolio Reporting Reforms
Disclosure Changes Aim to Reduce Burden, Boost Efficiency – February 18, 2026 | Washington, D.C. The U.S. Securities and...
MHRA Seizes 20M Illegal ED Pills in UK Crackdown
LONDON, UNITED KINGDOM — February 13, 2026 The Medicines and Healthcare products Regulatory Agency (MHRA) has seized nearly 20...
Corruption Index 2025 Flags Global Governance Risks
BERLIN, Germany, Feb. 10, 2026 — The release of the Corruption Perceptions Index (CPI) 2025 by Transparency International has...
NIH Launches East Palestine Health Research Program
EAST PALESTINE, Ohio, Feb. 3, 2026 — The National Institutes of Health (NIH), part of the U.S. Department of...
USITC Opens Section 337 Probe Into Medical Imaging Devices
Washington, D.C. | January 29, 2026 — The U.S. International Trade Commission (USITC) has formally instituted a Section 337...
ASPCA Cites Systemic USDA Lapses in Commercial Dog Breeder Oversight
Washington, D.C., January 27, 2026 — A new report released by the ASPCA has revealed widespread animal welfare violations...